Day One Biopharmaceuticals Normalized Basic EPS (Quarterly) Analysis

Day One Biopharmaceuticals, Inc. (DAWN)

8.25 -0.02 (-0.24%) USD | NASDAQ | Dec 16, 16:00

8.25 0.00 (0.00%) Pre-Market: 20:00

View Normalized Basic EPS (Quarterly) for DAWN.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Normalized Basic EPS (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Normalized Basic EPS (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Normalized Basic EPS (Quarterly) Benchmarks

Start Trial

Mersana Therapeutics, Inc.	Upgrade
Iovance Biotherapeutics, Inc.	Upgrade
Lantheus Holdings, Inc.	Upgrade
Travere Therapeutics, Inc.	Upgrade
Xenetic Biosciences, Inc.	Upgrade